Showing results (381-390 of 443) with videos related to
Sort By:
Pageof 45
Blood Advances|October 25, 2019
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapyMazyar Shadman, Jordan Gauthier, Kevin A Hay, et al.British Journal of Haematology|September 2, 2008
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experienceAndrew R Rezvani, Lalitha Norasetthada, Ted Gooley, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantationRyan D Cassaday, Barry E Storer, Mohamed L Sorror, et al.Bone Marrow Transplantation|September 27, 2020
Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approachMasumi Ueda Oshima, Brenda M Sandmaier, Effie Petersdorf, et al.Blood|July 2, 2002
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialMary E D Flowers, Pablo M Parker, Laura J Johnston, et al.Medical Physics|July 3, 2015
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID cameraBrian W Miller, Sofia H L Frost, Shani L Frayo, et al.Blood|October 24, 2002
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseasesDietger Niederwieser, Michael Maris, Judith A Shizuru, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantationMohamed L Sorror, Rainer F Storb, Brenda M Sandmaier, et al.Transplantation|April 11, 2014
Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantationMarco Mielcarek, Anna Yasmine Kirkorian, Robert C Hackman, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III studyFabrizio Carnevale-Schianca, Wendy Leisenring, Paul J Martin, et al.Pageof 45